Persistent sepsis-induced hypotension without hyperlactatemia: Is it really septic shock?

被引:66
作者
Hernandez, Glenn [1 ]
Castro, Ricardo [1 ]
Romero, Carlos [1 ]
de la Hoz, Claudio [1 ]
Angulo, Daniela [1 ]
Aranguiz, Ignacio [1 ]
Larrondo, Jorge [1 ]
Bujes, Andres [1 ]
Bruhn, Alejandro [1 ]
机构
[1] Pontificia Univ Catolica Chile, Dept Med Intens, Santiago, Chile
关键词
Septic shock; Lactate; Circulatory dysfunction; Perfusion; Definition; EMERGENCY-DEPARTMENT PATIENTS; GOAL-DIRECTED THERAPY; MANAGEMENT; NOREPINEPHRINE; LACTATE; MORTALITY; HYDROCORTISONE; EPINEPHRINE; SURVIVAL;
D O I
10.1016/j.jcrc.2010.09.007
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: The prognostic value of hyperlactatemia in septic shock is unquestionable. However, as current definitions do not include hyperlactatemia as a mandatory criterion, some hypotensive patients may be diagnosed as having septic shock despite exhibiting normolactatemia. The significance of persistent sepsis-induced hypotension without hyperlactatemia is unclear. Is it really septic shock? Our aim was to determine differences in outcome between patients diagnosed as having septic shock but exhibiting normal vs elevated lactate levels during evolution. We also explored the potential implications of including hyperlactatemia as an obligatory diagnostic criterion. Methods: We performed retrospective analyses on a cohort of 302 septic shock patients. Results: When we divided patients according to the presence of hyperlactatemia, 34% evolved without hyperlactatemia and exhibited a very low mortality risk ( 7.7% compared with 42.9% of those with hyperlactatemia). These patients also presented less severe organ dysfunctions and higher central venous O-2 saturation values, and required lower norepinephrine doses. The potential inclusion of hyperlactatemia in septic shock definition would reduce incidence in 34% but increase absolute mortality risk in 11%. Conclusions: Persistent sepsis-induced hypotension without hyperlactatemia may not constitute a real septic shock. Our results support the need to review the current definition of septic shock. Hyperlactatemia could represent an objective parameter worth to be explored as a potential diagnostic criterion for septic shock. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:435.e9 / 435.e14
页数:6
相关论文
共 27 条
[1]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[2]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[3]   Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock:: a randomised trial [J].
Annane, Djillali ;
Vignon, Philippe ;
Renault, Alain ;
Bollaert, Pierre-Edouard ;
Charpentier, Claire ;
Martin, Claude ;
Troche, Gilles ;
Ricard, Jean-Damien ;
Nitenberg, Gerard ;
Papazian, Laurent ;
Azoulay, Elie ;
Bellissant, Eric .
LANCET, 2007, 370 (9588) :676-684
[4]  
[Anonymous], 2008, INTENS CARE MED, DOI [DOI 10.1007/s00134-007-0934-2, DOI 10.1007/s00134-008-1040-9]
[5]   Hemodynamic monitoring in shock and implications for management International Consensus Conference, Paris, France, 27-28 April 2006 [J].
Antonelli, Massimo ;
Levy, Mitchell ;
Andrews, Peter J. D. ;
Chastre, Jean ;
Hudson, Leonard D. ;
Manthous, Constantine ;
Meduri, G. Umberto ;
Moreno, Rui P. ;
Putensen, Christian ;
Stewart, Thomas ;
Torres, Antoni .
INTENSIVE CARE MEDICINE, 2007, 33 (04) :575-590
[6]   MULTICENTER STUDY OF EARLY LACTATE CLEARANCE AS A DETERMINANT OF SURVIVAL IN PATIENTS WITH PRESUMED SEPSIS [J].
Arnold, Ryan C. ;
Shapiro, Nathan I. ;
Jones, Alan E. ;
Schorr, Christa ;
Pope, Jennifer ;
Casner, Elisabeth ;
Parrillo, Joseph E. ;
Dellinger, R. Phillip ;
Trzeciak, Stephen .
SHOCK, 2009, 32 (01) :35-39
[7]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[8]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[9]  
Castro R, 2008, MINERVA ANESTESIOL, V74, P223
[10]   High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock [J].
Cornejo, R ;
Downey, P ;
Castro, R ;
Romero, C ;
Regueira, T ;
Vega, J ;
Castillo, L ;
Andresen, M ;
Dougnac, A ;
Bugedo, G ;
Hernandez, G .
INTENSIVE CARE MEDICINE, 2006, 32 (05) :713-722